Yahoo Finance • last year Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock? Yahoo Finance • last year bluebird bio Details Plans for the Commercial Launch of LYFGENIA™ Gene Therapy for Patients Ages 12 and Older with Sickle Cell Disease and a History...